Application | Comment | Organism |
---|---|---|
pharmacology | the enzyme is a target for specific inhibitor design in therapy of neurodegenerative disorders, overview | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
recombinant expression | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(3-mercaptopropyl)-pentanedioic acid | 2-MPPA, specific, potent, competitive inhibition, has higher oral bioavailability compared to 2-PMPA, acts neuroprotective in vivo, e.g. in case of ischemic stroke, and provides analgesia | Homo sapiens | |
2-(3-mercaptopropyl)-pentanedioic acid | 2-MPPA, specific, potent, competitive inhibition, acts neuroprotective in vivo, e.g. in case of ischemic stroke, and provides analgesia | Rattus norvegicus | |
2-(phosphonomethyl)-pentanedioic acid | 2-PMPA, specific, potent, competitive inhibition, acts neuroprotective in vivo, e.g. in case of ischemic stroke, and provides analgesia | Homo sapiens | |
2-(phosphonomethyl)-pentanedioic acid | 2-PMPA, specific, potent, competitive inhibition, acts neuroprotective in vivo, e.g. in case of ischemic stroke, and provides analgesia | Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
brush border | - |
Homo sapiens | 5903 | - |
membrane | - |
Homo sapiens | 16020 | - |
plasma membrane | - |
Homo sapiens | 5886 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | interacts with the glutamate recognition site | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | Homo sapiens | the enzyme is involved in glutamate-mediated neurodegenerative disorders, enzyme inhibition is a mechanism for reduction of excitotoxic glutamate | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? | |
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | Rattus norvegicus | the enzyme is involved in glutamate-mediated neurodegenerative disorders, enzyme inhibition is a mechanism for reduction of excitotoxic glutamate | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
bifunctional enzyme | - |
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
brain | - |
Rattus norvegicus | - |
glial cell | - |
Homo sapiens | - |
prostate cancer cell | - |
Homo sapiens | - |
prostate gland | prostate form of the enzyme is termed prostate-specific membrane antigen | Homo sapiens | - |
small intestine | membrane brush border | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | bifunctional enzyme performing folate hydrolase and N-acetylated alpha-linked acidic dipeptidase, NAALADase, activities | Homo sapiens | ? | - |
? | |
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | the enzyme is involved in glutamate-mediated neurodegenerative disorders, enzyme inhibition is a mechanism for reduction of excitotoxic glutamate | Homo sapiens | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? | |
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | the enzyme is involved in glutamate-mediated neurodegenerative disorders, enzyme inhibition is a mechanism for reduction of excitotoxic glutamate | Rattus norvegicus | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? | |
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | i.e. NAAG | Homo sapiens | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? | |
N-acetyl-alpha-L-aspartyl-L-glutamate + H2O | i.e. NAAG | Rattus norvegicus | N-acetyl-alpha-L-aspartate + L-glutamate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GCP II | - |
Homo sapiens |
GCP II | - |
Rattus norvegicus |
N-Acetylated alpha-linked acidic dipeptidase | - |
Homo sapiens |
N-Acetylated alpha-linked acidic dipeptidase | - |
Rattus norvegicus |
NAALADase | - |
Homo sapiens |
NAALADase | - |
Rattus norvegicus |
Prostate-specific membrane antigen | - |
Homo sapiens |
PSMA | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0000002 | - |
2-(phosphonomethyl)-pentanedioic acid | - |
Homo sapiens | |
0.00003 | - |
2-(3-mercaptopropyl)-pentanedioic acid | - |
Homo sapiens |